Kymera Therapeutics, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2023
Total Assets: $575.8M
Liabilities Breakdown FY2023
Total Liabilities: $180.8M
Asset Breakdown
Total Assets: $575.8M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $110.0M | 19.1% |
| Accounts Receivable | $15.0M | 2.6% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $48.1M | 8.4% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $402.7M | 69.9% |
Liabilities Breakdown
Total Liabilities: $180.8M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $7.1M | 3.9% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $173.7M | 96.1% |